DPP-4 inhibitors × glycemic control

TrialDiabetes care2013

Effects of adding linagliptin to basal insulin regimen for inadequately controlled type 2 diabetes: a ≥52-week randomized, double-blind study.

Hannele Yki-Järvinen et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedrandomised · 1,261 people · 2013

Randomised comparison

Lowered glycemic control

−0.65percentage points−0.74 to −0.55

As reported

difference −0.65 %, 95% CI −0.74 to −0.55

One number in the abstract

the abstract, start to end

respectively (treatment difference -0.65% [95% CI -0.74 to -0.55] [-7.1

← favours treatmentfavours comparator →
could be chance
Glycemic control
−0.65−0.74 to −0.55
DPP-4 inhibitorsGlycemic control

DPP-4 inhibitors × glycemic controlhelps?replicated

unlikelylikely
0.820.82 without it
← favours treatmentfavours comparator →
this papermore certainless certain
1 / 5

63 papers cite itlatest 60 shown

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 24062327